NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $686,086 | -2.1% | 26,990 | +39.2% | 0.00% | 0.0% |
| Q1 2023 | $700,949 | +8.7% | 19,390 | +19.0% | 0.00% | 0.0% |
| Q4 2022 | $645,084 | -61.0% | 16,290 | -53.4% | 0.00% | -50.0% |
| Q3 2022 | $1,654,000 | +8.0% | 34,940 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,531,000 | -49.7% | 34,940 | -16.9% | 0.00% | -33.3% |
| Q1 2022 | $3,042,000 | -22.9% | 42,052 | -13.6% | 0.00% | 0.0% |
| Q4 2021 | $3,944,000 | -8.4% | 48,650 | +31.5% | 0.00% | -25.0% |
| Q3 2021 | $4,306,000 | -34.4% | 36,997 | -12.6% | 0.00% | -42.9% |
| Q2 2021 | $6,564,000 | -3.3% | 42,349 | -13.0% | 0.01% | -12.5% |
| Q1 2021 | $6,788,000 | -24.3% | 48,661 | -6.0% | 0.01% | -27.3% |
| Q4 2020 | $8,963,000 | +18.7% | 51,778 | -4.4% | 0.01% | +10.0% |
| Q3 2020 | $7,548,000 | +20.2% | 54,184 | +3.0% | 0.01% | +11.1% |
| Q2 2020 | $6,282,000 | +25.5% | 52,584 | +5.1% | 0.01% | +12.5% |
| Q1 2020 | $5,004,000 | -15.4% | 50,047 | -0.6% | 0.01% | -11.1% |
| Q4 2019 | $5,918,000 | +17.6% | 50,347 | -14.0% | 0.01% | +12.5% |
| Q3 2019 | $5,033,000 | +34.9% | 58,547 | +1.7% | 0.01% | +33.3% |
| Q2 2019 | $3,731,000 | +14.4% | 57,547 | +10.3% | 0.01% | +20.0% |
| Q1 2019 | $3,262,000 | +151.3% | 52,185 | +56.3% | 0.01% | +150.0% |
| Q4 2018 | $1,298,000 | -6.6% | 33,385 | +37.0% | 0.00% | 0.0% |
| Q3 2018 | $1,389,000 | +478.8% | 24,363 | +638.3% | 0.00% | – |
| Q4 2016 | $240,000 | -14.6% | 3,300 | +22.5% | 0.00% | – |
| Q3 2016 | $281,000 | +1.1% | 2,693 | -62.6% | 0.00% | – |
| Q4 2014 | $278,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |